Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children

Italian Journal of Pediatrics

Volumn 35, Issue 22, 2009, Pages

  El Din Elshazly, Lerine Bahy ^a   Youssef, Azza M ^a   Mahmoud, Nermine H ^a   Ibrahim, Mona M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHROMATIN ANTIBODY; IMMUNOGLOBULIN; LIVER ANTIGEN; MICROSOME ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PROGNOSIS; RELAPSE; SCHOOL CHILD;

EID: 67849119307     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-35-22     Document Type: Article

References (25)

1. Vergani D and Mieli-Vergani G. (2008): Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol; 14(21): 3306-3312
2. Czaja AJ and Freese DK. (2002): Diagnosis and treatment of autoimmune hepatitis. Hepatology; 36(2): 479-497
3. Czaja AJ and Norman (2003): Autoantibodies in the diagnosis and management of the liver disease. J Clin Gastroenterol; 37(4):315-329
4. Czaja AJ, Shums Z, Binder WL, Lewis SJ, Nelson VJ and Norman GL. (2003): Frequency and significance of antibodies to chromatin in autoimmune hepatitis. Dig. Dis. Sci. 48(8): 1658-1664
5. Czaja AJ, Shums Z and Norman GL.(2002): Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity; 35(8):475-483
6. 7- Alvarez F, Berg PA, Bianchi FB. Burroughs AK, Cancado EL. et al. (1999): International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5): 929-938 (Pubitemid 29514229)
7. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. (2004): Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol; 2(7): 625-631
8. Czaja AJ. (2005): Autoantibodies in autoimmune liver disease. Adv Clin Chem; 40: 127-164
9. Czaja AJ, Shums Z, Norman GL. (2004): Non standard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity; 37(3): 195-201.
10. Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, and Portmann B. et al. (2002): Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology; 35(3): 658-664
11. Czaja AJ, Dos Santos RM, Porto A, Santrach PJ, Moore SB et al. (1998): Immune phenotype of chronic liver disease, Dig Sci; 43(9): 2149-2155.
12. Gregorio GR, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M et al. (1997): Autoimmune hepatitis in childhood. A twenty years survey. Hepatology; (25): 541-547.
13. Najafi M, Kianifar HR, Mir-Nasseri SM, Khodadad A. (2005): Autoimmune hepatitis in children, clinical features and biochemical of Iranian children. Govaresh; 10(2): 103-107
14. Rafeey M, Kianrad M. and Hasani A. (2007): Autoimmune hepatitis in Iranian children.Indian J.Gatroenterol.;26(1): 11-13
15. Porta G, Miura IK, Cardoso RA, Bittencout PL, Vianna R, Pugliese RPS et al. (2000): Clinical and laboratory features of Brazilian children with autoimmune hepatitis type 1 and 2. J Pediatr Gastroenterol Nutr; 31(2): S4.
16. McFarlane IG. (2002): Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin in Liver Dis; 6(3): 605-621
17. Krawitt EL. (2008): Clinical features and management of autoimmune hepatitis. World J Gastroenterol, 14(21): 3301-3305
18. Czaja AJ, Manns MP, McFarlane IG. and Hoofnagle JH. (2000): Autoimmune hepatitis: the investigational and clinical challenges. Hepatology; 31(5): 1194-1200
19. Ottinger R, Brunnberg A, Gerner P, Wintermeyer P, Jeuke A. & Wirth S. (2005): Clinical features and biochemical data of caucasian children at diagnosis of autoimmune hepatitis. J. Autoimmunity; 24(1): 79-84.
20. Badia I, Ferro A, Galoppa C, Carabajal P, De Matteo E, Marco I. (2000): Autoimmune hepatitis type 1: experience with 107 pediatric patients. J Pediatr Gastroenterol Nutr; 31(2): S203.
21. 22- Saadah OI, Smith AL, Hardikar W. (2001): Longterm outcome of autoimmune hepatitis in children. J Gastroenterol Hepatol; 16(11): 1297-1302 (Pubitemid 34088279)
22. 23- Miyakawa H, Kawashima Y, Kitazawa E, Kawaguchi N, Kato T, Kikuchi K et al. (2003): Low frequency of anti SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. Journal of Autoimmunity; 21(1): 77-82. (Pubitemid 36871689)
23. Czaja AJ, Donaldson PT. (2002): Gender effects and synergisms with histocompatibility leukocyte antigens in type I autoimmune hepatitis. Am J Gastroenterol; 97(8): 2051-2057
24. Li L, Chen M, Huang DY. & Nishioka M. (2000): Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J. Gastroenterol. Hepatol; 15(10): 1176-1182
25. Amoura Z, Kutouzov S, Piette J-C. (2000): The role of nucleosomes in lupus. Curr Open Rheumatol; 12(5): 369-373